Hudson Bay Capital Management
PFE icon

Hudson Bay Capital Management’s Pfizer PFE Stock Holding History

Hudson Bay Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,300
Closed -$492K – 1576
2025
Q2 		$492K Sell
20,300
-479,700
-96% -$11.2M ﹤0.01% 1088
2025
Q1 		$12.7M Buy
+500,000
New +$13.1M 0.04% 344
2019
Q3 		– Sell
-2,740,400
Closed -$113M – 466
2019
Q2 		$113M Sell
2,740,400
-2,740,400
-50% -$109M 2.58% 7
2019
Q1 		$221M Buy
+5,480,800
New +$219M 2.85% 4

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hudson Bay Capital Management's PFE Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Pfizer (PFE) stake by 49% in Q1 2026, selling an estimated $2.26M and leaving 90,000 shares worth $2.53M. The position accounts for 0.01% of the portfolio, ranked #709.

Hudson Bay Capital Management first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $142M in Q2 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hudson Bay Capital Management held 90,000 shares of Pfizer worth $2.53M as of Q1 2026.
  • Hudson Bay Capital Management sold 85,000 Pfizer shares in Q1 2026, an estimated $2.26M.
  • Pfizer made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #709 holding.
  • Hudson Bay Capital Management first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
  • Hudson Bay Capital Management's Pfizer position peaked at $142M in Q2 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.